Interleukin 17-producing T-helper cells and autoimmune diseases: Time for a paradigm shift? Takashi Yamamura Invited Commentary 03 June 2007 Pages: 93 - 95
Web Alert Edwin Chan, MD Department of Medicine/Clinical Pharmacology, New York University School of Medicine, New Bellevue Hospital, 16N1, 550 First Avenue, New York, NY 10016, USA. E-mail: chane01@nyu.edu EditorialNotes 03 June 2007 Pages: 96 - 97
Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus Deborah M. FriedmanAnn RupelJill P. Buyon OriginalPaper 03 June 2007 Pages: 101 - 108
Neurologic manifestations of the antiphospholipid syndrome Jose F. RoldanRobin L. Brey OriginalPaper 03 June 2007 Pages: 109 - 115
New insights into central nervous system lupus: A clinical perspective John G. Hanly OriginalPaper 03 June 2007 Pages: 116 - 124
The role of preventive cardiology in systemic lupus erythematosus Jennifer Rae ElliottSusan ManziDaniel Edmundowicz OriginalPaper 03 June 2007 Pages: 125 - 130
Mycophenolate mofetil: a promising novel therapy in systemic sclerosis Manu JainJohn Varga Clinical Trials Report 03 June 2007 Pages: 133 - 135
New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma David J. AbrahamBeate EckesThomas Krieg OriginalPaper 03 June 2007 Pages: 136 - 143
Management of interstitial lung disease in systemic sclerosis: Lessons from SLS and FAST Nihal FathiDaniel E. FurstPhilip J. Clements OriginalPaper 03 June 2007 Pages: 144 - 150
Outcome measures in systemic sclerosis: An update on instruments and current research Dinesh KhannaPeter A. Merkel OriginalPaper 03 June 2007 Pages: 151 - 157
Therapy of pulmonary arterial hypertension in systemic sclerosis: An update Christopher P. DentonSvetlana I. Nihtyanova OriginalPaper 03 June 2007 Pages: 158 - 164
Autoimmunity in systemic sclerosis: Current concepts Francesco BoinAntony Rosen OriginalPaper 03 June 2007 Pages: 165 - 172
Current concepts in normal and defective angiogenesis: Implications for systemic sclerosis Mary Jo Mulligan-KehoeMichael Simons OriginalPaper 03 June 2007 Pages: 173 - 179